NASDAQ · Drug Manufacturers - Specialty & Generic

Indivior Pharmaceuticals Inc (INDV) Stock

$40.48 -0.12% NASDAQ: INDV Healthcare

Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence.

Valuation

MetricValue
Price$40.48
Market Cap$5.05B
P/E Ratio20.16
P/B Ratio-35.28
P/S Ratio3.92
EPS (TTM)$1.64
52-Week High$42.81
52-Week Low$16.69
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-142.01%
ROA20.97%
ROCE102.87%
Gross Margin83.11%
Operating Margin33.31%
Net Margin19.44%
Debt/Equity-3.53
Current Ratio0.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$791.0M$901.0M$1.1B$1.2B$1.2B
Operating Profit$213.0M$-81.0M$-156.0M$32.0M$265.0M
Net Profit$205.0M$-44.0M$-129.0M$2.0M$210.0M
EPS$1.31$-0.37$0.01$0.02$1.64
Op Margin26.9%-9.0%-14.3%2.7%21.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.8B$1.8B$1.8B$1.3B$1.2B
Total Liabilities$1.6B$1.7B$2.0B$1.7B$1.3B
Cash$1.1B$778.0M$316.0M$319.0M$195.0M
Borrowings$286.0M$277.0M$283.0M$375.0M$351.0M

Latest News

Indivior’s Triple Russell 2000 Defensive Inclusion Could Be A Game Changer For Indivior Pharmaceuticals (INDV) Simply Wall St. · Jun 30, 2026 ACAD Stock Up as CHMP Backs Daybu for EU Approval in Rett Syndrome Zacks · Jun 29, 2026 Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable Zacks · Jun 29, 2026 Bull of the Day: Neurocrine Biosciences (NBIX) Zacks · Jun 29, 2026 IONS Out-Licenses ex-U.S. Rights for Rare Neurology Drug to Recordati Zacks · Jun 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$353.0M$-4.0M$-300.0M$36.0M$-27.0M
Investing Cash Flow$-48.0M$-227.0M$-148.0M$40.0M$-132.0M
Financing Cash Flow$-109.0M$-100.0M$-55.0M$-197.0M$-10.0M
Net Cash Flow$244.0M$-328.0M$-458.0M$3.0M$-124.0M
Free Cash Flow$319.0M$-9.0M$-353.0M$7.0M$-93.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA18.27
FCF Yield-1.84%
Quick Ratio0.55
Interest Coverage5.89
Return 1Y159.29%
Return 3Y67.63%
Return 5Y283.41%

Ownership

Insiders Held1.98%
Institutions Held108.89%
Institutions Float Held111.09%
Institutional HolderSharesReport Date
Blackrock Inc.18,542,2202026-03-31
Vanguard Portfolio Management LLC7,891,8192026-03-31
Oaktree Capital Management LP6,984,1022026-03-31
Vanguard Capital Management LLC5,586,5762026-03-31
State Street Corporation4,903,9932026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACAD $29.21 +2.67% 8.94 $5.00B 0.00%
ADMA $8.71 -0.91% 12.17 $2.02B 0.00%
AMRXAmneal Pharmaceuticals, Inc. $18.01 +0.47% 47.29 $5.75B 0.00%
CRNX $83.81 -0.09% -8.57 $8.87B 0.00%
HNGE $75.11 +1.08% -13.65 $5.81B 0.00%

About Indivior Pharmaceuticals Inc

Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.

Indivior Pharmaceuticals Inc (INDV) stock trades at $40.48 with a market capitalization of $5.05B. The stock is valued at a price-to-earnings (P/E) ratio of 20.16, price-to-book of -35.28, price-to-sales of 3.92. Over the past 52 weeks the stock has ranged between $16.69 and $42.81, and currently trades 5.4% below its 52-week high.

On profitability, Indivior Pharmaceuticals Inc generates a return on equity (ROE) of -142.01%, return on capital employed of 102.87%, an operating margin of 33.31%, a net profit margin of 19.44%.

Official website: www.indivior.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides